Treatment Choices in Refractory RA: Jack Cush, MD

preview_player
Показать описание
Dr. Cush presents Treatment Choices in Refractory RA, during the RheumNow Live 2022 meeting held in March 2022.
  1. RheumNow
  2. Rheumatoid
  3. arthritis
  4. Rheumatology
  5. Lupus
  6. Vasculitis
Рекомендации по теме
Treatment Choices in 0:37:16

Treatment Choices in Refractory RA: Jack Cush, MD

Overcoming Challenges in 0:40:21

Overcoming Challenges in the Management of Refractory Rheumatoid Arthritis

RNL 2021 - 0:25:27

RNL 2021 - Difficult, Refractory RA - Dr. Maya Buch

Emerging Therapeutic Options 0:22:33

Emerging Therapeutic Options for Relapsed/Refractory Multiple Myeloma

Improving Outcomes for 0:45:08

Improving Outcomes for Patients With Refractory Rheumatoid Arthritis

What Clinical Trials 0:59:57

What Clinical Trials Do Not Teach Us: How to Achieve Remission in Rheumatoid Arthritis

What are new 0:44:05

What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson

Treating New & 0:32:30

Treating New & Refractory SJIA patients by Dr Jennifer Huggins

New Directions in 0:47:17

New Directions in Treating Multiple Myeloma in the Era of Novel Agents

ARC Talks: Contemporary 0:49:29

ARC Talks: Contemporary Management of AL Amyloidosis

Dr. Sheeba Thomas 0:33:10

Dr. Sheeba Thomas Relapsed Refractory Treatments

Advances in Rheumatoid 0:32:50

Advances in Rheumatoid Arthritis

Current and Future 0:46:00

Current and Future Treatment of Multiple Myeloma

JAK-Inhibition in Immune-Mediated 0:43:42

JAK-Inhibition in Immune-Mediated Diseases (IMiDs)

NextGen 2024: Treating 0:13:48

NextGen 2024: Treating Refractory Adult Still’s Patients

Rheumatoid Arthritis: Update 1:01:58

Rheumatoid Arthritis: Update on Treatment Strategies | Larry W. Moreland, MD

TNR – Rheumatoid 1:08:28

TNR – Rheumatoid Arthritis: Revolutionary Advances in Therapy

JAK Inhibitors in 0:26:03

JAK Inhibitors in Rheumatoid Arthritis

RNL 2022: Rheumatoid 1:02:54

RNL 2022: Rheumatoid Arthritis - Best Management

Optimal usage of 0:18:35

Optimal usage of carfilzomib and pomalidomide in treating relapsed/refractory myeloma

Best of ASH 0:58:48

Best of ASH 2019

How I diagnose 0:53:53

How I diagnose interstitial lung disease in different immune-mediated disorders? | Dr Bracaglia

Treatment of cutaneous 0:25:50

Treatment of cutaneous manifestations in SLE

Minimizing Complications in 0:49:15

Minimizing Complications in Cirrhosis with Dr. Marsano